Choreo, LLC Astrazeneca PLC Transaction History

Choreo, LLC

$6.88 Billion
Q4 2024

A detailed history of Choreo, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Choreo, LLC holds 50,375 shares of AZN stock, worth $3.63 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

50,375

Previous 52,042 3.2%

Holding current value

$3.63 Million

Previous $4.06 Million 18.62%

% of portfolio

0.05%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$63.2 - $79.58 $105,354 - $132,659	-1,667 Reduced 3.2%	50,375 $3.3 Million
Q3 2024 Nov 07, 2024	BUY	$76.67 - $87.62 $318,717 - $364,236	4,157 Added 8.68%	52,042 $4.06 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $2.99 Million - $3.62 Million	44,808 Added 1456.22%	47,885 $3.73 Million
Q1 2024 May 02, 2024	BUY	$61.03 - $69.57 $187,789 - $214,066	3,077 New	3,077 $208,000
Q3 2019 Jun 04, 2020	SELL	$40.12 - $45.47 $196,226 - $222,393	-4,891 Closed	0 $0
Q2 2019 Jun 04, 2020	SELL	$37.28 - $41.68 $35,788 - $40,012	-960 Reduced 16.41%	4,891 $202,000
Q1 2019 Jun 04, 2020	SELL	$35.49 - $43.02 $25,481 - $30,888	-718 Reduced 10.93%	5,851 $237,000
Q4 2018 Jun 04, 2020	SELL	$36.86 - $41.49 $40,840 - $45,970	-1,108 Reduced 14.43%	6,569 $249,000
Q2 2018 Jun 04, 2020	SELL	$34.55 - $37.05 $54,969 - $58,946	-1,591 Reduced 17.17%	7,677 $270,000
Q1 2018 Jun 04, 2020	BUY	$32.97 - $36.63 $29,837 - $33,150	905 Added 10.82%	9,268 $324,000
Q4 2017 Jun 04, 2020	BUY	$32.09 - $34.78 $17,200 - $18,642	536 Added 6.85%	8,363 $290,000
Q3 2017 Jun 04, 2020	BUY	$28.96 - $34.0 $226,669 - $266,118	7,827	7,827 $265,000

Others Institutions Holding AZN

# of Institutions

1,350

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.

Account